ir.amphastar.comInvestors | Amphastar Pharmaceuticals, Inc.
ir.amphastar.com Profile
ir.amphastar.com
Maindomain:amphastar.com
Title:Investors | Amphastar Pharmaceuticals, Inc.
Description:The Investor Relations website contains information about Amphastar Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
Discover ir.amphastar.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.amphastar.com Information
Website / Domain: |
ir.amphastar.com |
HomePage size: | 42.513 KB |
Page Load Time: | 0.486011 Seconds |
Website IP Address: |
23.10.139.135 |
Isp Server: |
Akamai Technologies Inc. |
ir.amphastar.com Ip Information
Ip Country: |
United States |
City Name: |
San Jose |
Latitude: |
37.339389801025 |
Longitude: |
-121.89495849609 |
ir.amphastar.com Keywords accounting
ir.amphastar.com Httpheader
Accept-Ranges: bytes |
Content-Encoding: gzip |
Content-Language: en |
Content-Type: text/html; charset=UTF-8 |
device: desktop |
ETag: "1613082661" |
Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
Last-Modified: Thu, 11 Feb 2021 22:31:01 GMT |
Link: http://ir.amphastar.com/; rel="shortlink", http://ir.amphastar.com/; rel="canonical", http://ir.amphastar.com/investor-relations; rel="alternate"; hreflang="en", http://ir.amphastar.com/investor-relations; rel="revision" |
Referrer-Policy: no-referrer-when-downgrade |
X-Age: 2307 |
X-Cache-Hits: 1 |
X-Content-Type-Options: nosniff |
X-Drupal-Dynamic-Cache: UNCACHEABLE |
X-Frame-Options: SAMEORIGIN |
X-Request-ID: v-d211a712-6cb8-11eb-a762-e3461afb94d8 |
X-UA-Compatible: IE=edge |
X-XSS-Protection: 1; mode=block |
Content-Length: 11183 |
Cache-Control: public, max-age=0, s-maxage=2700 |
Expires: Thu, 11 Feb 2021 23:09:30 GMT |
Date: Thu, 11 Feb 2021 23:09:30 GMT |
Connection: keep-alive |
Vary: Accept-Encoding |
Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
ir.amphastar.com Meta Info
charset="utf-8"/ |
content="Amphastar Pharmaceuticals, Inc." property="og:site_name"/ |
content="website" property="og:type"/ |
content="The Investor Relations website contains information about Amphastar Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts." name="description"/ |
content="http://ir.amphastar.com/investor-relations" property="og:url"/ |
content="Investors | Amphastar Pharmaceuticals, Inc." property="og:title"/ |
content="no-referrer" name="referrer"/ |
content="The Investor Relations website contains information about Amphastar Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts." property="og:description"/ |
content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
content="width" name="MobileOptimized"/ |
content="true" name="HandheldFriendly"/ |
content="width=device-width, initial-scale=1.0" name="viewport"/ |
content="width=device-width, initial-scale=0.4" name="viewport"/ |
23.10.139.135 Domains
ir.amphastar.com Similar Website
Domain |
WebSite Title |
zuchepharma.trustpass.alibaba.com | ZUCHE PHARMACEUTICALS PRIVATE LIMITED - Pharmaceuticals,Medical Devices |
aeriepharma.com | Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals |
lifelinepharm.tracktracerx.com | Lifeline Pharmaceuticals, LLCâs Login Page | Lifeline Pharmaceuticals, LLC |
shop.neilmed.com | Welcome - NeilMed Pharmaceuticals, Inc. |
titanpharm.com | About Titan Pharmaceuticals Titan Pharmaceuticals Inc |
www1.actelion.us | Actelion Pharmaceuticals US, Inc |
support.sppirx.com | Spectrum Pharmaceuticals, Inc. |
avadel.com | Avadel Pharmaceuticals |
contravir.com | Hepion Pharmaceuticals |
akorn.com | Akorn Pharmaceuticals |
pharma.bayer.com | Home | Pharmaceuticals |
inovio.com | INOVIO Pharmaceuticals |
investor.cyclacel.com | Overview | Cyclacel Pharmaceuticals, Inc. |
investor.ironwoodpharma.com | Ironwood Pharmaceuticals, Inc. - Home |
ir.syndax.com | Investors | Syndax Pharmaceuticals, Inc. |
ir.amphastar.com Traffic Sources Chart
ir.amphastar.com Alexa Rank History Chart
ir.amphastar.com Html To Plain Text
Skip to main navigation Home About Us Our Products Investors Media/News Careers Contact Us Investor Relations Investors Press Releases Events & Presentations Corporate Governance Financials & Filings Stock Information Investor FAQs Contact Us Shareholder Tools Printed Materials Email Alerts Downloads RSS Print Share Investors We are a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and branded injectable and inhalation products. We currently manufacture and sell over 20 branded and generic products in the U.S. and are developing a portfolio of over 20 commercial injectable and inhalation products that primarily target markets with high technical barriers to entry. More More Press Releases Dec 29, 2020 Amphastar Announces Approval for Glucagon for Injection Kit, 1mg RANCHO CUCAMONGA, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) has approved its Abbreviated New Drug Application (“ANDA”) for Glucagon for Injection Emergency Kit, 1 mg. Dec 29, 2020 Amphastar Announces Approval for Glucagon for Injection Kit, 1mg RANCHO CUCAMONGA, Calif. , Dec. 29, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. , (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) has approved its Abbreviated New Drug Application (“ANDA”) for Glucagon for Injection Emergency Kit, 1 mg. More Events & Presentations More events are coming soon. More Data Provided by Refinitiv. Minimum 15 minutes delayed. THIS CONFERENCE CALL MAY CONTAIN FORWARD-LOOKING STATEMENTS INCLUDING STATEMENTS RELATING TO AMPHASTAR PHARMACEUTICALS. THESE STATEMENTS ARE NOT HISTORICAL FACTS, BUT RATHER BASED ON AMPHASTAR PHARMACEUTICAL'S CURRENT EXPECTATIONS, ESTIMATES AND PROJECTIONS REGARDING AMPHASTAR PHARMACEUTICAL'S BUSINESS, OPERATIONS AND OTHER SIMILAR OR RELATED FACTORS. WORDS SUCH AS MAY, WILL, COULD, WOULD, SHOULD, ANTICIPATE, PREDICT, POTENTIAL, CONTINUE, EXPECTS, INTENDS, PLANS, PROJECTS, BELIEVES, ESTIMATES AND OTHER SIMILAR OR RELATED EXPRESSIONS ARE USED TO IDENTIFY THESE FORWARD-LOOKING STATEMENTS. THESE STATEMENTS ARE ONLY PREDICTIONS AND ARE SUCH ARE NOT GUARANTEES OF FUTURE PERFORMANCE. AND THEY INVOLVE RISKS, UNCERTAINTIES AND ASSUMPTIONS THAT ARE DIFFICULT OR IMPOSSIBLE TO PREDICT. ACTUAL RESULTS MAY DIFFER MATERIALLY FROM THOSE IN THE FORWARD-LOOKING STATEMENTS. AS A RESULT OF A NUMBER OF FACTORS INCLUDING THESE DESCRIBED FROM TIME TO TIME AND AMPHASTAR PHARMACEUTICALS' FILINGS WITH THE SEC.* Copyright ©2021 Amphastar Pharmaceuticals, Inc. Privacy Terms & Conditions This site is intended for residents of the United States...
ir.amphastar.com Whois
"domain_name": "AMPHASTAR.COM",
"registrar": "Network Solutions, LLC",
"whois_server": "whois.networksolutions.com",
"referral_url": null,
"updated_date": [
"2020-05-28 23:40:24",
"2020-05-28 23:40:33"
],
"creation_date": "1998-09-02 04:00:00",
"expiration_date": "2023-09-01 04:00:00",
"name_servers": [
"NS37.WORLDNIC.COM",
"NS38.WORLDNIC.COM"
],
"status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"emails": [
"abuse@web.com",
"domainnameadmin@amphastar.com"
],
"dnssec": "unsigned",
"name": "Amphastar Pharmaceuticals, Inc.",
"org": "Amphastar Pharmaceuticals, Inc.",
"address": "11570 6TH ST",
"city": "RANCHO CUCAMONGA",
"state": "CA",
"zipcode": "91730-6025",
"country": "US"